4//SEC Filing
Caplan Jay David 4
Accession 0000950170-24-106530
CIK 0001572616other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 6:39 PM ET
Size
10.0 KB
Accession
0000950170-24-106530
Insider Transaction Report
Form 4
Caplan Jay David
President, Chief Product Off.
Transactions
- Exercise/Conversion
Stock Option
2024-09-12−95,484→ 0 totalExercise: $1.70Exp: 2024-11-10→ Common Stock (95,484 underlying) - Exercise/Conversion
Common Stock
2024-09-12$1.70/sh+95,484$162,323→ 95,484 total - Sale
Common Stock
2024-09-12$2.90/sh−65,000$188,474→ 30,484 total
Holdings
- 358,806(indirect: By Trust)
Common Stock
- 118,810(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $2.85 to $3.06. The Reporting Person undertakes to provide upon request the Staff of the Securities and Exchange Commission, the Issuer, or any stockholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- [F2]The option is fully vested and exercisable.
Documents
Issuer
FRACTYL HEALTH, INC.
CIK 0001572616
Entity typeother
Related Parties
1- filerCIK 0001419217
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 6:39 PM ET
- Size
- 10.0 KB